Rapid disease progression following discontinuation of ibrutinib in patients with chronic lymphocytic leukemia treated in routine clinical practice

Paul J. Hampel, Wei Ding, Timothy G. Call, Kari G. Rabe, Saad S. Kenderian, Thomas E. Witzig, Eli Muchtar, Jose F. Leis, Asher A. Chanan-Khan, Amber B. Koehler, Amie L. Fonder, Susan M. Schwager, Susan L. Slager, Tait D. Shanafelt, Neil E. Kay, Sameer A. Parikh

Research output: Contribution to journal › Article › peer-review

15 Scopus citations

Fingerprint

Dive into the research topics of 'Rapid disease progression following discontinuation of ibrutinib in patients with chronic lymphocytic leukemia treated in routine clinical practice'. Together they form a unique fingerprint.

Medicine & Life Sciences